About the trial team
Who is organising the trial?
The NHS-Galleri trial is organised and funded by a number of partner organisations.
The Cancer Research UK Cancer Prevention Trials Unit at QMUL
The trial is run by The Cancer Research UK Cancer Prevention Trials Unit at QMUL, a team of cancer researchers and trial managers at Queen Mary University of London (QMUL). They coordinate this trial and analyse the results. The unit was based at King’s College London before moving to QMUL.
NHS England
The study is in partnership with the National Health Service (NHS) England. They provided follow-up and care related to the trial. The National Disease Registration Service provides data for the trial.
GRAIL
GRAIL, Inc. is a company in the United States (US) that developed the Galleri® test. They have also set up a branch in the UK, GRAIL Bio UK Ltd. (GRAIL), which is the main funder and organiser of this trial.
Who are the researchers leading the trial?
The Chief Investigators for the trial are Professor Richard Neal, a GP researcher at University of Exeter, and Professor Charles Swanton, a cancer researcher at University College London and the Francis Crick Institute. The Co-Investigator and Lead Statistician for the trial is Professor Peter Sasieni, a cancer researcher and statistician at Queen Mary University of London.
Professor Richard Neal FRCGP MBChB PhD is a part time GP and Professor of Primary Care. His research examines the interface between primary care/general practice and cancer, with a particular focus in cancer diagnostics.
Professor Charles Swanton FRCP BSc PhD is a clinician scientist. His research focuses on the management of metastatic cancer.
Professor Peter Sasieni CBE FMedSci PhD is Professor of Cancer Epidemiology and Director of the Cancer Research UK Cancer Prevention Trials Unit. His research focuses on cancer screening.
Who developed the Galleri test?
The Galleri test was developed by researchers at GRAIL, Inc. in the US.
Is anyone else involved?
The NHS-Galleri trial is being delivered in specific areas of England known as Cancer Alliances. These are local NHS partnerships that work together to improve cancer services. They help support the delivery of the trial in your area.
The trial is taking place in the following eight Cancer Alliance areas in England:
- Cheshire and Merseyside
- East of England
- Greater Manchester
- Kent and Medway
- East Midlands
- West Midlands
- Northern
- South East London
GRAIL collaborates with patients and the public to make sure that information for participants in the NHS-Galleri trial is clear and understandable.
The trial uses the services of third-party organisations in the UK and outside the UK to help run the trial. They might handle information about people taking part in the trial. They will be required to do this safely and securely.
Review status
Last updated: 30 May 2026